Addepalli, Murali Krishna,Charych, Deborah H.,Kantak, Seema,Lee, Steven Robert
申请号：
AU2015220408
公开号：
AU2015220408A1
申请日:
2015.02.20
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The invention relates to (among other things) method of administering to a patient suffering from a cancer, the method comprising the steps of: (a) an IL-2Rβ-activating amount of a long acting, IL-2Rβ-selective agonist； and (b) a CTLA-4 pathway-inhibiting amount of an anti-CTLA-4 antibody or a PD-1 pathway-inhibiting amount of an anti-PD-1 antibody.
